The obstetric outcome following treatment in a cohort of patients with antiphospholipid antibody syndrome in a tertiary care center

Journal of Postgraduate Medicine

Volumn 57, Issue 1, 2011, Pages 16-19

  Dadhwal, V ^a   Sharma, A K ^a   Deka, D ^a   Gupta, B ^a   Mittal, S ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antiphospholipid antibody syndrome; Aspirin; Heparin; Pregnancy outcome

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; HEPARIN; IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BIRTH RATE; CLINICAL ARTICLE; COHORT ANALYSIS; DRUG SUBSTITUTION; FEMALE; FETUS DEATH; HUMAN; HYPERTRANSAMINASEMIA; INTRAUTERINE GROWTH RETARDATION; LIVE BIRTH; LOW DRUG DOSE; MATERNAL AGE; MISSED ABORTION; PARITY; PREECLAMPSIA; PREGNANCY OUTCOME; RETROSPECTIVE STUDY; SOLUTIO PLACENTAE; TERTIARY HEALTH CARE; THROMBUS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; BIRTH RATE; COHORT STUDIES; FEMALE; FETAL GROWTH RETARDATION; FIBRINOLYTIC AGENTS; GESTATIONAL AGE; HEPARIN; HOSPITALS, TEACHING; HUMANS; INDIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79951540392     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.74285     Document Type: Article

References (15)

1. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-63. (Pubitemid 34983997)
2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
3. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005;CD002859.
4. Roubey RA. Treatment of the antiphospholipid syndrome. Curr Opin Rheumatol 2002;14:238-42. (Pubitemid 34439086)
5. Girardi G. Heparin treatment in pregnancy loss: Potential therapeutic benefits beyond anticoagulation. J Reprod Immunol 2005;66:45-51. (Pubitemid 40798126)
6. Derksen R, de Groot P. The obstetric antiphospholipid syndrome. J Reprod Immunol 2008;77:41-50.
7. Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: Results from the randomized, controlled HepASA Trial. J Rheumatol 2009;36:279-87.
8. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002;46:1019-27. (Pubitemid 34303815)
9. Ruffatti A, Tonello M, Cavazzana A, Bagatella P, Pengo V. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thromb Res 2009;123:482-7.
10. Nodler J, Moolamalla SR, Ledger EM, Nuwayhid BS, Mulla ZD. Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: Analysis of a population-based hospital dataset. BMC Pregnancy Childbirth 2009;9:11.
11. Bats AS, Lejeune V, Cynober E, Safar E, Gonzales M, Milliez J, et al. Antiphospholipid syndrome and second or third trimester fetal death: Follow -up in the next pregnancy. Eur J Obstet Gynecol Reprod Biol 2004;114:125-9. (Pubitemid 38622070)
12. Sebire NJ, Backos M, Goldin RD, Regan L. Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. Br J Obstet Gynaecol 2002;109:570-3. (Pubitemid 37338000)
13. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin. Am J Obstet Gynecol 1992;166:1318-23.
14. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989;160:439-43. (Pubitemid 19065395)
15. Hutton B, Sharma R, Fergusson D, Tinmouth A, Herbert P, Jamieson J, et al. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: A systematic review. Br J Obstet Gynaecol 2007;114:134-42. (Pubitemid 46089441)